116 related articles for article (PubMed ID: 27510158)
1. Inhibitory effects of B‑cell translocation gene 2 on skin cancer cells via the Wnt/β‑catenin signaling pathway.
Gao SS; Yang XH; Wang M
Mol Med Rep; 2016 Oct; 14(4):3464-8. PubMed ID: 27510158
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells.
Mao B; Xiao H; Zhang Z; Wang D; Wang G
Mol Med Rep; 2015 Oct; 12(4):4917-24. PubMed ID: 26151427
[TBL] [Abstract][Full Text] [Related]
3. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
Wang C; Wang J; Liu H; Fu Z
Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
[TBL] [Abstract][Full Text] [Related]
5. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro.
Zhang L; Huang H; Wu K; Wang M; Wu B
Mol Biol Rep; 2010 Jul; 37(6):2579-86. PubMed ID: 19728149
[TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of Wnt/β‑catenin target genes promotes proliferation and invasion of liver cancer stem cells.
Chen W; Zhang YW; Li Y; Zhang JW; Zhang T; Fu BS; Zhang Q; Jiang N
Mol Med Rep; 2016 Apr; 13(4):3466-74. PubMed ID: 26956539
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA induces apoptosis via inhibition of Wnt/β‑catenin/MGMT signaling in AtT‑20 cells.
Li ZY; Huang GD; Chen L; Zhang C; Chen BD; Li QZ; Wang X; Zhang XJ; Li WP
Mol Med Rep; 2017 Nov; 16(5):5908-5914. PubMed ID: 28849207
[TBL] [Abstract][Full Text] [Related]
8. Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells.
Zubair H; Lim IK; Safi SZ; Rehman F; Imran M
Ann Clin Lab Sci; 2020 Nov; 50(6):711-716. PubMed ID: 33334784
[TBL] [Abstract][Full Text] [Related]
9. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
10. Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells.
Wei S; Hao C; Li X; Zhao H; Chen J; Zhou Q
Tumour Biol; 2012 Aug; 33(4):1223-30. PubMed ID: 22392501
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of BTG2 suppresses growth, migration, and invasion of human renal carcinoma cells in vitro.
Sima J; Zhang B; Sima XY; Mao YX
Neoplasma; 2016; 63(3):385-93. PubMed ID: 26925784
[TBL] [Abstract][Full Text] [Related]
12. [Enhancement of B-cell translocation gene-2 inhibits proliferation and metastasis of colon cancer cells].
Jiang Z; Zhang L; Zhang L; Wang S; Zheng M; Li Y; Liu X
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):330-5. PubMed ID: 26463021
[TBL] [Abstract][Full Text] [Related]
13. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
Imran M; Lim IK
Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
[TBL] [Abstract][Full Text] [Related]
16. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
[TBL] [Abstract][Full Text] [Related]
18. BTG2 overexpression increases the radiosensitivity of breast cancer cells in vitro and in vivo.
Hu X; Xing L; Jiao Y; Xu J; Wang X; Han A; Yu J
Oncol Res; 2013; 20(10):457-65. PubMed ID: 24308156
[TBL] [Abstract][Full Text] [Related]
19. BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.
Hu XD; Meng QH; Xu JY; Jiao Y; Ge CM; Jacob A; Wang P; Rosen EM; Fan S
Biochem Biophys Res Commun; 2011 Jan; 404(4):903-9. PubMed ID: 21172304
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]